Emma L. B. Soldner

Chronic placental ischemia alters amniotic fluid milieu and results in impaired glucose tolerance, insulin resistance and hyperleptinemia in young rats

A. Gingery, J. Gilbert, N. Bozadjieva, 2010, Experimental biology and medicine.

Matrix Metalloproteinase-Mediated Blood-Brain Barrier Dysfunction in Epilepsy

E. Abner, R. Kryscio, A. Hartz, 2018, The Journal of Neuroscience.

Amyloid- Contributes to Blood–Brain Barrier Leakage in Transgenic Human Amyloid Precursor Protein Mice and in Humans With Cerebral Amyloid Angiopathy

F. Schlachetzki, I. Mihaljevic, H. Klünemann, 2011 .

Amyloid- (cid:1) Contributes to Blood–Brain Barrier Leakage in Transgenic Human Amyloid Precursor Protein Mice and in Humans With Cerebral Amyloid Angiopathy

F. Schlachetzki, I. Mihaljevic, H. Klünemann, 2011 .

Amyloid-&bgr; Contributes to Blood–Brain Barrier Leakage in Transgenic Human Amyloid Precursor Protein Mice and in Humans With Cerebral Amyloid Angiopathy

Ivan Mihaljevic, U. Bogdahn, G. Schuierer, 2012, Stroke.

Inhibition of human microsomal PGE2 synthase‐1 reduces seizure‐induced increases of P‐glycoprotein expression and activity at the blood‐brain barrier

R. Kryscio, A. Hartz, A. Pekcec, 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Cytosolic phospholipase A2 is a key regulator of blood‐brain barrier function in epilepsy

R. Kryscio, A. Hartz, A. Pekcec, 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

P-gp Protein Expression and Transport Activity in Rodent Seizure Models and Human Epilepsy.

Yu Zhong, A. Hartz, A. Pekcec, 2017, Molecular pharmaceutics.

Matrix Metalloproteinase-Mediated Blood-Brain Barrier Dysfunction in Epilepsy

E. Abner, R. Kryscio, A. Hartz, 2018, The Journal of Neuroscience.